AllianceBernstein’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Hold |
67,790
| – | – | ﹤0.01% | 2718 |
|
|
2025
Q1 | $538K | Sell |
67,790
-210
| -0.3% | -$1.67K | ﹤0.01% | 2525 |
|
|
2024
Q4 | $862K | Hold |
68,000
| – | – | ﹤0.01% | 2397 |
|
|
2024
Q3 | $947K | Hold |
68,000
| – | – | ﹤0.01% | 2355 |
|
|
2024
Q2 | $937K | Hold |
68,000
| – | – | ﹤0.01% | 2341 |
|
|
2024
Q1 | $1.12M | Buy |
68,000
+16,500
| +32% | +$273K | ﹤0.01% | 2202 |
|
|
2023
Q4 | $752K | Buy |
51,500
+16,430
| +47% | +$240K | ﹤0.01% | 2408 |
|
|
2023
Q3 | $430K | Sell |
35,070
-8,240
| -19% | -$101K | ﹤0.01% | 2638 |
|
|
2023
Q2 | $517K | Buy |
43,310
+5,910
| +16% | +$70.6K | ﹤0.01% | 2625 |
|
|
2023
Q1 | $500K | Sell |
37,400
-4,500
| -11% | -$60.2K | ﹤0.01% | 2577 |
|
|
2022
Q4 | $902K | Buy |
41,900
+3,900
| +10% | +$83.9K | ﹤0.01% | 2335 |
|
|
2022
Q3 | $761K | Sell |
38,000
-4,400
| -10% | -$88.1K | ﹤0.01% | 2430 |
|
|
2022
Q2 | $759K | Buy |
+42,400
| New | +$759K | ﹤0.01% | 2484 |
|